Quick Answer
Ocugen, Inc. reported Total Revenue of $4.41 million for fiscal year 2025.
Ocugen, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $4.41M +8.8% |
$4.05M -32.8% |
$6.04M +142.6% |
$2.49M | $0.00 -100.0% |
$43.0K |
| Revenue (ASC 606) | $4.41M +8.8% |
$4.05M -32.8% |
$6.04M +142.6% |
$2.49M | — | — |
| Net Income | -$67.85M -25.5% |
-$54.05M +14.3% |
-$63.08M +27.3% |
-$86.80M -48.7% |
-$58.37M -167.5% |
-$21.82M -7.8% |
| Diluted EPS | — | — | -$0.26 +35.0% |
-$0.40 -33.3% |
-$0.30 +3.2% |
-$0.31 +78.8% |
| Total Assets | $43.52M -47.2% |
$82.44M -14.4% |
$96.30M -32.1% |
$141.73M +34.0% |
$105.76M +286.3% |
$27.38M +62.9% |
| Cash and Equivalents | — | — | $68.26M -47.4% |
$129.77M +36.7% |
$94.96M +295.0% |
$24.04M +222.9% |
| Long-Term Debt | $27.54M +0.7% |
$27.34M +2484.6% |
$1.06M -38.9% |
$1.73M +1.1% |
$1.71M -6.1% |
$1.82M +70.0% |
| Stockholders Equity | -$12.17M -141.1% |
$29.63M -54.3% |
$64.90M -48.3% |
$125.52M +37.6% |
$91.20M +323.2% |
$21.55M +95.6% |
| R&D Expense | $39.75M +23.7% |
$32.13M -18.8% |
$39.57M | — | — | — |
| Operating Income | -$62.92M -14.9% |
-$54.76M +16.4% |
-$65.53M +26.4% |
-$89.07M -53.5% |
-$58.03M -172.6% |
-$21.29M -50.3% |
| Shares Outstanding | 312.38M +7.2% |
291.37M +13.6% |
256.57M +15.8% |
221.60M +11.1% |
199.38M +8.4% |
184.01M +249.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.75M | +54.2% | +27.6% |
| Revenue (ASC 606) | September 30, 2025 | $1.75M | +54.2% | +27.6% |
| Net Income | September 30, 2025 | -$20.05M | -54.6% | -36.0% |
| Diluted EPS | June 30, 2024 | -$0.04 | +60.0% | +20.0% |
| Total Assets | September 30, 2025 | $57.60M | -7.0% | +7.5% |
| Cash and Equivalents | June 30, 2024 | $15.70M | -77.8% | -40.5% |
| Long-Term Debt | September 30, 2025 | $28.40M | +1707.8% | +1.3% |
| Stockholders Equity | September 30, 2025 | $3.53M | -91.3% | +15.8% |
| R&D Expense | September 30, 2025 | $11.15M | +37.5% | +32.7% |
| Operating Income | September 30, 2025 | -$17.62M | -33.0% | -27.8% |
| Shares Outstanding | September 30, 2025 | 312.32M | +7.6% | +6.9% |
- Ocugen, Inc. reported Total Revenue of $4.41 million for fiscal year 2025.
- Ocugen, Inc. showed an increase of +8.8% in Total Revenue compared to the prior fiscal year.
- Ocugen, Inc. reported Revenue (ASC 606) of $4.41 million for fiscal year 2025.
- Ocugen, Inc. showed an increase of +8.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Ocugen, Inc. reported Net Income of -$67.85 million for fiscal year 2025.
- Ocugen, Inc. showed a decrease of -25.5% in Net Income compared to the prior fiscal year.
- Ocugen, Inc. reported Diluted EPS of $0.26 per share (loss) for fiscal year 2023.
- Ocugen, Inc. showed an increase of +35.0% in Diluted EPS compared to the prior fiscal year.
- Ocugen, Inc. reported Total Assets of $43.52 million for fiscal year 2025.
- Ocugen, Inc. showed a decrease of -47.2% in Total Assets compared to the prior fiscal year.
- Ocugen, Inc. reported Cash and Equivalents of $39.46 million for fiscal year 2023.
- Ocugen, Inc. showed a decrease of -26.2% in Cash and Equivalents compared to the prior fiscal year.
- Ocugen, Inc. reported Long-Term Debt of $27.54 million for fiscal year 2025.
- Ocugen, Inc. showed an increase of +0.7% in Long-Term Debt compared to the prior fiscal year.
- Ocugen, Inc. reported Stockholders Equity of -$12.17 million for fiscal year 2025.
- Ocugen, Inc. showed a decrease of -141.1% in Stockholders Equity compared to the prior fiscal year.
- Ocugen, Inc. reported R&D Expense of $39.75 million for fiscal year 2025.
- Ocugen, Inc. showed an increase of +23.7% in R&D Expense compared to the prior fiscal year.
- Ocugen, Inc. reported Operating Income of -$62.92 million for fiscal year 2025.
- Ocugen, Inc. showed a decrease of -14.9% in Operating Income compared to the prior fiscal year.
- Ocugen, Inc. reported Shares Outstanding of 312.38 million shares for fiscal year 2025.
- Ocugen, Inc. showed an increase of +7.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: